Try our corporate solution for free!

Pharmaceutical industry in Russia - statistics & facts

The pharmaceutical industry, which involves the development, production, and marketing of medications, is actively expanding in Russia, projected to grow to 2.5 billion Russian rubles by 2023. One of the factors shaping the market is the government's push for national security in medicine supply, especially considering that major foreign producers, including Bayer and Novartis, suspended at least some operations in the country in 2022 due to the war in Ukraine. The industry is dependent on import trade, which was valued at over 951 billion Russian rubles in 2021. Another driving force of the industry is the evolution of online retail of medicines, legalized during the COVID-19 pandemic. In 2021, the pharma e-commerce market in Russia reached 168 billion Russian rubles.

Pharmaceutical production in Russia

Russian companies produced pharmaceuticals worth 624.5 billion Russian rubles in 2021, up 17 percent from the previous year. The production value has steadily increased since 2018. However, in physical terms, production decreased in 2021 compared to the previous year, reaching 4.13 billion packages. Two domestic companies, OTCPharm and Biocad, were among the 10 leading pharmaceutical producers by revenue. Biocad was one of the companies manufacturing the COVID-19 vaccine Sputnik V which was developed by Gamaleya Research Institute. OTCPharm produced an antiviral medication Arbidol, the highest-earning brand in the market.

OTC pharmaceuticals in Russia

Over 60 percent of total packages of pharmaceuticals sold in Russia in 2021 were over-the-counter products. In other words, to purchase them, customers did not need a prescription from a doctor. The revenue of OTC pharmaceuticals in the country was forecast at 2.8 billion U.S. dollars in 2021, which was the eighth-highest figure worldwide. The major segment in that category was cold and cough remedies, with their revenue in Russia projected to exceed 1.5 billion U.S. dollars in 2025. Another trending OTC segment was biologically active additives (BAAs), or dietary supplements, and vitamins. An average person consumed 2.3 packages of BAAs in the first nine months of 2021.

Interesting statistics

In the following 6 chapters, you will quickly find the 38 most important statistics relating to "Pharmaceutical industry in Russia".


Get in touch with us. We are happy to help.
Statista Locations
Contact Vianny Gutierrez-Cruz
Vianny Gutierrez-Cruz
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Ziyan Zhang
Ziyan Zhang
Customer Relations– Contact (Asia)

Mon - Fri, 11:30am - 10pm (IST)

Contact Kisara Mizuno
Kisara Mizuno
Customer Success Manager– Contact (Asia)

Mon - Fri, 9:30am - 5:30pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Associate Director - LAC– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)